Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 15;15(1):47.
doi: 10.3390/bios15010047.

Enhanced Electrochemiluminescence from Ruthenium-Tagged Immune Complex at Flexible Chains for Sensitive Analysis of Glutamate Decarboxylase Antibody

Affiliations

Enhanced Electrochemiluminescence from Ruthenium-Tagged Immune Complex at Flexible Chains for Sensitive Analysis of Glutamate Decarboxylase Antibody

Yuyao Zhang et al. Biosensors (Basel). .

Abstract

Herein, a sensitive electrochemiluminescence (ECL) immunosensor is designed by immobilizing ruthenium-tagged immune complexes at flexible poly-ethylene-glycol (PEG) chains on the electrode surface, which offers more freedom for the collision of the ruthenium complex at the electrode during the initial ECL reaction. The electrochemical characterizations confirm the loose structure of the assembled layer with the immune complex, providing an increase in the current and the resultant enhanced ECL emissions. Comparing the sensors with the rigid structure, a 34-fold increase in the maximal ECL emission is recorded when PEG3400 is used as a linker. Using the optimized protocol, the prepared immunosensor exhibits a wide-ranging linear response to the model antibody (glutamate decarboxylase antibody) ranging from 10 pg/mL to 10 ng/mL. The detection limit is almost two orders lower than the value using the classic enzyme-linked immunosorbent assay, which offers a new design to enhance ECL emissions and the resultant analytical performance.

Keywords: GADA; electrochemiluminescence; flexible PEG chain; immunosensors; ruthenium complex.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Schematic illustration of the construction process of the ECL immunosensor with PEG chains.
Figure 2
Figure 2
(A) CVs of the immunosensor fabrication in 0.1 M PBS (pH = 7.4) with the potential range from −0.2 to 0.8 V and (B) EIS characterization of the immunosensor fabrication in 5.0 mM K3Fe(CN)6/K4Fe(CN)6 at the frequency range from 0.01 Hz to 10 KHz. Blank line: Au/HS-PEG(3400)-COOH; red line: Au/HS-PEG(3400)-COOH/GAD65 antigen; green line: Au/HS-PEG(3400)-COOH/GAD65 antigen/BSA; blue line: Au/HS-PEG(3400)-COOH/GAD65 antigen/BSA/GADA; purple line: Au/HS-PEG(3400)-COOH/GAD65 antigen/BSA/GADA/Ru-GAD65. (C) CVs and (D) ECL intensity of the immunosensor with TGA (blank line) and HS-PEG(3400)-COOH (red line) as the connection chains with 100 mM TPrA in 0.1 M PBS.
Figure 3
Figure 3
(A) CVs of immunosensors with PEG length and (B) EISs of immunosensor with PEG length (black line: 2000 Da; red line: 3400 Da, green line: 5000 Da and blue line: 10,000 Da). (C) ECL responses of immunosensor with PEG length (Mw ~ 2000, 3400, 5000 and 10,000 Da); (D) ECL intensity of immunosensors with different concentrations of SH-PEG(3400)-COOH (black: 1 μM; red: 5 μM; green: 10 μM; blue: 50 μM; cyan: 100 μM; magenta: 1 mM; yellow: 10 mM).
Figure 4
Figure 4
(A) ECL responses of the immunosensor toward diverse concentrations of GADA modified with HS-PEG(3400)-COOH; (B) the selectivity of the immunosensor with various autoantibodies (GADA, IAA Ab, IA2 Ab and ZnT8 Ab); (C) the calibration curve of the ECL immunosensor for GADA modified with HS-PEG(3400)-COOH; and (D) the calibration curve of the ECL immunosensor for GADA modified with TGA at various concentrations.

Similar articles

References

    1. Syed F.Z. Type 1 Diabetes Mellitus. Ann. Intern. Med. 2022;175:ITC33–ITC48. doi: 10.7326/AITC202203150. - DOI - PubMed
    1. Katsarou A., Gudbjörnsdottir S., Rawshani A., Dabelea D., Bonifacio E., Anderson B.J., Jacobsen L.M., Schatz D.A., Lernmark Å. Type 1 Diabetes Mellitus. Nat. Rev. Dis. Primers. 2017;3:17016. doi: 10.1038/nrdp.2017.16. - DOI - PubMed
    1. Redondo M.J., Morgan N.G. Heterogeneity and Endotypes in Type 1 Diabetes Mellitus. Nat. Rev. Endocrinol. 2023;19:542–554. doi: 10.1038/s41574-023-00853-0. - DOI - PubMed
    1. Xia Y., Xie Z., Huang G., Zhou Z. Incidence and Trend of Type 1 Diabetes and the Underlying Environmental Determinants. Diabetes Metab. Res. 2019;35:e3075. doi: 10.1002/dmrr.3075. - DOI - PubMed
    1. Liu J., Ren Z.-H., Qiang H., Wu J., Shen M., Zhang L., Lyu J. Trends in the Incidence of Diabetes Mellitus: Results from the Global Burden of Disease Study 2017 and Implications for Diabetes Mellitus Prevention. BMC Public Health. 2020;20:1415. doi: 10.1186/s12889-020-09502-x. - DOI - PMC - PubMed

LinkOut - more resources